Sun Pharmaceutical Industries Ltd connected Thursday said the Ministry of Corporate Affairs has levied penalties connected definite past and contiguous directors and officials, including CMD Dilip Shanghvi, for non-disclosure and not obtaining support of its committee and shareholders for definite related-party transactions.
The institution has received an bid from the Regional Director, North Western Region, Ministry of Corporate Affairs, for alleged violations of definite provisions of the Companies Act, 2013, Sun Pharmaceutical Industries said successful a regulatory filing.
"A full combined compounding interest is levied connected definite past and contiguous directors/officers of the institution -- Dilip Shanghvi (Rs 9.5 lakh), Sudhir Valia (Rs 9 lakh); Sailesh Desai (Rs 9 lakh); K Subramanian (Rs 1.5 lakh); Uday Baldota (Rs 6 lakh) and C Muralidharan (Rs 1.5 lakh)," the filing said.
This substance pertains to the earlier probe carried retired by Sebi, successful which a colony was reached with the markets regulator successful February 2021 without admittance oregon denial of guilt; however, connected the aforesaid matter, the Ministry of Corporate Affairs besides initiated an probe successful parallel successful 2019, it added.
These further orders pertain to the exertion of compounding of offences for alleged usurpation nether Section 129 and Section 188 for non-disclosure of definite transactions with related parties successful the board's study and fiscal statements for the fiscal years ranging from 2015-16 to 2018-19, the institution said.
Further, the alleged violations besides see not obtaining support of the board/shareholders for a related enactment transaction with Aditya Medisales Ltd for the fiscal years 2014-15 to 2017-18, Sun Pharma said.
For the consequent periods, the related enactment transactions person been duly disclosed successful the board's reports/financial statements, and indispensable approvals person been obtained, it said.